MedTrace Logo

Pharmacokinetics and Pharmacodynamics of Anthocyanins

NCT03650140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-01-09

No results posted yet for this study

Summary

The purpose of the study is to establish the pharmacokinetic parameters of cherry juice concentrate and identify its potential to alter inflammatory markers in gout patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Tart cherry extract 60 mL

Subjects will receive a single 60 mL oral dose of tart cherry extract.

DIETARY_SUPPLEMENT

Tart cherry extract 120 mL

Subjects will receive a single 120 mL oral dose of tart cherry extract.

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Naomi Schlesinger, MD · Robert Wood Johnson Medical School/ Rutgers RWJMS Gout Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-06-01
Completion
2022-06-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03650140 on ClinicalTrials.gov